14-fold increased prevalence of rare glucokinase gene variant carriers in unselected Danish patients with newly diagnosed type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review


  • Fulltext

    Final published version, 713 KB, PDF document

  • Anette P. Gjesing
  • Anne Cathrine B. Thuesen
  • Christian T. Have
  • Mette Hollensted
  • Jens Steen Nielsen
  • Lotte B. Christensen
  • Reimar W. Thomsen
  • Sarah Gersing
  • Henrik T. Sørensen
  • Ivan Brandslund
  • Henning Beck-Nielsen

Aims: Rare variants in the glucokinase gene (GCK) cause Maturity-Onset Diabetes of the Young (MODY2/GCK-MODY). We investigated the prevalence of GCK variants, phenotypic characteristics, micro- and macrovascular disease at baseline and follow-up, and treatment among individuals with and without pathogenic GCK variants. Methods: This is a cross-sectional study in a population-based cohort of 5,433 individuals without diabetes (Inter99 cohort) and in 2,855 patients with a new clinical diagnosis of type 2 diabetes (DD2 cohort) with sequencing of GCK. Phenotypic characteristics, presence of micro- and macrovascular disease and treatment information were available for patients in the DD2 cohort at baseline and after an average follow-up of 7.4 years. Results: Twenty-two carriers of potentially deleterious GCK variants were found among patients with type 2 diabetes compared to three among 5,433 nondiabetic individuals [OR = 14.1 (95 % CI 4.2; 47.0), p = 8.9*10-6]. Patients with type 2 diabetes carrying GCK variants had significantly lower waist circumference, hip circumference and BMI, compared to non-carriers. Three GCK variant carriers with diabetes had microvascular complications during follow-up. Conclusions: Approximately 0.8% of Danish patients with newly diagnosed type 2 diabetes carry non-synonymous variants in GCK and resemble patients with GCK-MODY. Glucose-lowering treatment cessation should be considered in this subset of diabetes patients.

Original languageEnglish
Article number110159
JournalDiabetes Research and Clinical Practice
Number of pages9
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s)

    Research areas

  • Complications, Glucokinase, Macrovascular, Microvascular, MODY, Monogenic diabetes

Number of downloads are based on statistics from Google Scholar and www.ku.dk

No data available

ID: 333697133